Differential gene expression in ovarian carcinoma: Identification of potential biomarkers

American Journal of Pathology

Volumn 165, Issue 2, 2004, Pages 397-414

  Hibbs, Kathleen ^a   Skubitz, Keith M ^a   Pambuccian, Stefan E ^a   Casey, Rachael C ^a   Burleson, Kathryn M ^a   Oegema Jr , Theodore R ^b   Thiele, Jeannine J ^b   Grindle, Suzanne M ^b   Bliss, Robin L ^b   Skubitz, Amy P N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CELLULAR RETINOIC ACID BINDING PROTEIN 1; CLAUDIN; CLAUDIN 4; COLLAGEN TYPE 9; INTEGRIN; OSTEOGENIC PROTEIN 1; RETINOIC ACID BINDING PROTEIN; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY DISEASE; PRIORITY JOURNAL;

EID: 3242813597     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63306-8     Document Type: Article

References (86)

1. Ahmedin J, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics. CA Cancer J Clin 2003, 53:5-26
2. Verheijen RHM, von Mensdorff-Pouilly S, van Kamp GJ, Kenemans P: CA 125: fundamental and clinical aspects. Cancer Biol 1999, 9:117-124
3. Bast Jr RC, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G: Early detection of ovarian cancer: promise and reality. Ovarian Cancer. Edited by Stack MS, Fishman DA. Cancer Treatment and Research, vol 107 Edited by Rosen ST (Series Editor). Boston, Kluwer Academic Publishers, 2002, pp 61-97
4. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA 2001, 98:1176-1181
5. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ: Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001, 61:3869-3876
6. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287
7. Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson L, Knuutila S: Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 2001, 128:1-6
8. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J: Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999, 229:101-108
9. Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY, Hood L: Comparative hybridization of an array of 21,500 ovarian cDNA's for the discovery of genes overexpressed in ovarian carcinomas. Gene 1999, 238:375-385
10. Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC, Chang DD: Differential gene expression between normal and tumor-derived ovarian epithelial cells. Cancer Res 2000, 60:6744-6749
11. Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW: Prostatin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst 2001, 93:1458-1464
12. Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, Ochiai K, Takagi T, Nakamura Y: Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 2000, 60:5007-5011
13. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast Jr RC, James D, Couch FJ, Hartmann LC, Lillie J, Smith DL: Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 2001, 61:5895-5904
14. Bayani J, Brenton JD, Macgregor PF, Beheshti B, Albert M, Nallainathan D, Karaskova J, Rosen B, Murphy J, Laframboise S, Zanke B, Squire JA: Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res 2002, 62:3466-3476
15. Martoglio A, Tom BDM, Starkey M, Corps AN, Charnock-Jones DS, Smith SK: Changes in tumorigenesis and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. Mol Med 2000, 6:750-765
16. Suzuki S, Moore DH, Ginzinger DG, Godfrey TE, Barclay J, Powell B, Pinkel D, Zaloudek C, Lu K, Mills G, Berchuck A, Gray JW: An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res 2000, 60:5382-5385
17. Van Niekerk CC, Boerman OC, Ramaekers FCS, Poels LG: Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas. Am J Pathol 1991, 138:455-463
18. Van Niekerk CC, Ramaekers FCS, Hanselaar GJM, Aldeweireldt J, Poels LG: Changes in expression of differentiation markers between normal ovarian cells and derived tumors. Am J Pathol 1993, 142:157-177
19. Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford SL, Wolf J, Mills GB, Bast RC, Gershenson DM, Schmandt RE: Over-expression of NES-1 in epithelial ovarian carcinoma. Society of Gynecology 32nd Annual Meeting, Abstract p. 103
20. Tonin PN, Hudsno TJ, Rodier F, Bossolasco M, Lee PD, Novak J, Mandreson EN, Provencher D, Mes-Masson A: Microarray analysis of gene expression mirrors the biology of ovarian cancer model. Oncogene 2001, 20:6617-6626
21. Wong KK, Cheng RS, Mok SC: Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques 2001, 30:670-675
22. Su Al, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson Jr HF, Hampton GM: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001, 61:7388-7393
23. Dubeau L: The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 1999, 72:437-442
24. Feng H, Ghazizadeh M, Konishi H, Araki T: Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. Jpn J Clin Oncol 2002, 32:525-529
25. Alaiya AA, Franzen B, Hagman A, Silfversward C, Moberger B, Linder S, Auer G: Classification of human ovarian tumors using multivariate data analysis of polypeptide expression patterns. Int J Cancer 2000, 86:731-736
26. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359:572-577
27. Skubitz KM, Skubitz APN: Differential gene expression in renal-cell cancer. J Lab Clin Med 2002, 140:52-64
28. Skubitz KM, Skubitz APN: Differential gene expression in uterine leiomyoma. J Lab Clin Med 2003, 141:297-308
29. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868
30. Skubitz APN, Bast Jr RC, Wayner EA, Letourneau PC, Wilke MS: Expression of α6 and β4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am J Pathol 1996, 148:1445-1461
31. Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema Jr TR, Ruff LE, Skubitz APN: β1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol 2001, 159:2071-2080
32. Galmozzi E, Tomassetti A, Sforzini S, Mangiarotti F, Mazzi M, Nachmanoff K, Elwood PC, Canevari S: Exon 3 of the a folate receptor gene contains a 5′ splice site which confers enhanced ovarian carcinoma specific expression. FEBS Lett 2001, 502:31-34
33. Moyle M, Napier MA, McLean JW: Cloning and expression of a divergent integrin subunit β8. J Biol Chem 1991, 266:19650-19658
34. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge RJ, Sampath TK, Oppermann H: OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J 1990, 9:2085-2093
35. Morita K, Furuse M, Fujimoto K, Tsukita S: Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999, 96:511-516
36. Perala M, Hanninen M, Hastbacka J, Elima K, Vuorio E: Molecular cloning of the human alpha-2 (IX) collagen cDNA and assignment of the human COLGA2 gene to chromosome 1. FEBS Lett 1993, 319:177-180
37. Cornic M, Guidez F, Delva L, Agadir A, Degos L, Chomienne C: Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia. Bull Cancer 1992, 79:697-704
38. Murphy DB, Seeman S, Wiese S, Kirschner R, Grzeschik KH, Thies U: The human hepatocyte nuclear factor 3/fork head gene FKHL13: genomic structure and pattern of expression. Genomics 1997, 40:462-469
39. Schafer BW, Wicki R, Engelkamp D, Mattei M-G, Heizmann CW: Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995, 25:638-643
40. Giordano TJ, Shedden KA, Schwartz DR, Kuick R, Taylor JMG, Lee N, Misek DE, Greenson JK, Kardia SLR, Beer DG, Rennert G, Cho KR, Gruber SB, Fearon ER, Hanash S: Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001, 159:1231-1238
41. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET: Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst 2002, 94:990-1000
42. Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, Boyd J, Birrer MJ: Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin Cancer Res 2003, 9:4811-4818
43. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zuang Z, Goldstein SR, Weiss RA, Liotta LA: Laser capture microdissection. Science 1996, 274:998-1001
44. Luo L, Salunga RC, Guo H, Bittner A, Joy KC, Galindo JE, Xiao H, Rogers KE, Wan JS, Jackson MR, Erlander MG: Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med 1999, 5:117-122
45. Nishimura SL, Boylen KP, Einheber S, Milner TA, Ramos DM, Pytela R: Synaptic and glial localization of the integrin αvβ8 in mouse and rat brain. Brain Res 1998, 791:271-282
46. Mu D, Cambier S, Fiellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL: The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J Cell Biol 2002, 157:493-507
47. Belot N, Rorive S, Doyen I, LeFranc F, Bruyneel E, Dedecker R, Micik S, Brotchi J, Decaestecker C, Salmon I, Kiss R, Camby I: Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. Glia 2001, 36:375-390
48. Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A, Lemoine NR: Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 2002, 160:1745-1754
49. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG: Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001, 61:7878-7881
50. Mazzucchelli L: Protein S100A4: too long overlooked by pathologists? Am J Pathol 2002, 160:7-13
51. Brett W, Mandinova A, Remppis A, Sauder U, Ruter F, Heizmann CW, Aebi U, Zerkowski HR: Translocation of S100A1(1) calcium binding protein during heart surgery. Biochem Biophys Res Comm 2001, 284:698-703
52. Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, Borries M, Niroomand F, Pieske B, Janssen PML, Eschenhagen T, Karczewski P, Smith GL, Koch WJ, Katus HA, Remppis A: S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci USA 2001, 98:13889-13894
53. Sorci G, Agneletti AL, Donato R: Effects of S100A1 and S100B on microtubule stability. An in vitro study using Triton-cytoskeletons from astrocyte and myoblast cell lines. Neuroscience 2000, 99:773-783
54. Shrestha P, Muramatsu Y, Kudeken W, Mori M, Takai Y, Ilg EC, Schafer BW, Heizmann CW: Localization of Ca(2+)-binding S100 proteins in epithelial tumours of the skin. Virchows Arch 1998, 432:53-59
55. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH, Goggins M: Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002, 160:45-50
56. Wang G, Rudland PS, Whites MR, Barraclough R: Interaction in vivo and in vitro of the metastatic-inducing S100 protein, S100A4 (p9Ka) with S100A1. J Biol Chem 2000, 275:11141-11146
57. Yamamoto T, Saatcioglu F, Matsuda T: Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology 2002, 143:2635-2642
58. Raishankar D, McCulloch CA, Tenenbaum HC, Lekic PC: Osteogenic inhibition by rat periodontal ligament cells: modulation of bone morphogenic protein-7 activity in vivo. Cell Tissue Res 1998, 294:475-483
59. Hidaka C, Quitoriano M, Warren RF, Crystal RG: Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7. J Orthopaedic Res 2001, 19:751-758
60. Simon M, Maresh JG, Harris SE, Hernandez JD, Arar M, Olson MS, Abboud HE: Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 1999, 276:F382-F389
61. Ishibashi K, Sasaki S, Akiba T, Marumo F: Expression of bone morphogenic protein 7 mRNA in MDCK cells. Biochem Biophys Res Comm 1993, 193:235-239
62. Katoh M, Terada M: Overexpression of bone morphogenic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. J Gastroenterol 1996, 31:137-139
63. Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J, Waldman T: Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res 2002, 62:2744-2748
64. Imai N, Iwai A, Hatakeyama S, Masuzaki K, Kitagawa Y, Kato S, Hokari R, Kawaguchi A, Nagao S, Miyahara T, Itoh K, Miura S: Expression of bone morphogenetic proteins in colon carcinoma with heterotopic ossification. Pathol Int 2001, 51:643-648
65. Sulzbacher I, Birner P, Trieb K, Pichlbauer E, Lang S: The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. J Clin Pathol 2002, 55:381-385
66. Weber KL, Bolander ME, Rock MG, Pritchard D, Sarkar G: Evidence for the upregulation of osteogenic protein-1 mRNA expression in musculoskeletal neoplasms. J Orthopaedic Res 1998, 16:8-14
67. Lin DL, Tarnowski CP, Zhang J, Dai J, Rohn E, Patel AH, Morris MD, Keller ET: Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro. Prostate 2001, 47:212-221
68. Weber BL: Cancer genomics. Cancer Cell 2002, 1:37-47
69. Diab M, Wu JJ, Eyre DR: Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. Biochem J 1996, 314:327-332
70. Holden P, Canty EG, Mortier GR, Zabel B, Spranger J, Carr A, Grant ME, Loughlin JA, Briggs MD: Identification of novel pro-alpha-2(IX) collagen gene mutations in two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia. Am J Hum Genet 1999, 65:31-38
71. Wolanska M, Sobolewski K, Drozdzewicz M: Extracellular matrix components in ovarian tumors. Ginekologia Polska 1999, 70:179-185
72. Santala M, Risteli J, Ristell L, Puistola U, Kacinski BM, Stanley ER, Kauppila A: Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer. Br J Cancer 1998, 77:1825-1831
73. Zhu GG, Risteli J, Puistola U, Kauppila A, Ristela L: Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res 1993, 53:5028-5032
74. Kiyozuka Y, Nakagawa H, Senzaki H, Uemura Y, Adachi S, Teramoto Y, Matsuyama T, Bessho K, Tsubura A: Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer. Anticancer Res 2001, 21:1723-1730
75. Moser TL, Pizzo SV, Bafetti LM, Fishman DA, Stack MS: Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin. Int J Cancer 1996, 67:695-701
76. Parenti R, Wassef M, Cicirata F: Expression of CRABP I mRNA in fastigial cells of the developing cerebellum. Eur J Neurosci 2002, 15:211-215
77. Whitney D, Massaro GD, Massaro D, Clerch LB: Gene expression of cellular retinoid-binding proteins: modulation by retinoic acid and dexamethasone in postnatal rat lung. Pediatr Res 1999, 45:2-7
78. Mey J, McCaffery P, Klemeit M: Sources and sink of retinoic acid in the embryonic chick retina: distribution of aldehyde dehydrogenase activities, CRABP-I, and sites of retinoic acid inactivation. Brain Res Dev Brain Res 2001, 127:135-148
79. Vo HP, Crowe DL: Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion. Anticancer Res 1998, 18:217-224
80. Hillemanns P, Tannous-Khuri L, Koulos JP, Talmage D, Wright Jr TC: Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Am J Pathol 1992, 141:973-980
81. Di Fronzo G, Cappelletti V, Miodini P, Bertario L, Ravasi G: Role of cellular retinoic acid binding protein (cRABP) in patients with large bowel cancer. Cancer Detect Prevent 1987, 10:327-333
82. Chen J, Knowles HJ, Hebert JL, Hackett BP: Mutation of the mouse hepatocyte nuclear factor/forkhead homologue 4 gene results in an absence of cilia and random left-right asymmetry. J Clin Invest 1998, 102:1077-1082
83. Naiki T, Nagaki M, Shidoji Y, Kojima H, Imose M, Kato T, Ohishi N, Yagi K, Moriwaki H: Analysis of gene expression profile induced by hepatocyte nuclear factor 4 alpha in hepatoma cells using an oligo-nucleotide microarray. J Biol Chem 2002, 277:14011-14019
84. Tichelaar JW, Lim L, Costa RH, Whitsett JA: HNF-3/forkhead homologue-4 influences lung morphogenesis and respiratory epithelial cell differentiation in vivo. Dev Biol 1999, 213:405-417
85. Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z, Hu G: Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res 2001, 61:3176-3181
86. Scholler N, Fu N, Yang Y, Ye Z, Goodman GE, Hellstrom KE, Hellstrom I: Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci USA 1999, 96:11531-11536